Yasmin 21 Day (Yasmin 21 Day)3/0.03mg

$18.60

Each Yasmin box contains 21 pills of Drospirenone/Ethinyl Estradiol used for Birth Control to control the menstrual cycle and for acne conditions in women.

Active Ingrediant: Drospirenone/Ethinyl Estradiol
Generic Name: Yasmin 21 Day
Manufacturer: Bayer Schering Germany
Strength: 3/0.03mg
Dosage Type: Tablet
Packaging Type: Foil in Box
Contains: 1 TABLET

Inquire Us

Medication Safety Issues

Sound-alike/look-alike issues:

Yaz may be confused with Beyaz, Yasmin

Storage/Stability

Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).

Adverse Reactions

  • Frequency not defined. Reactions listed are based on reports for other agents in this same pharmacologic class (oral contraceptives) and may not be specifically reported for drospirenone/ethinyl estradiol.
  • Increased risk or evidence of association with use:
  • Cardiovascular: Arterial thromboembolism, cerebral thrombosis, hypertension, local thrombophlebitis, mesenteric thrombosis, myocardial infarction, pulmonary embolism, retinal thrombosis
  • Central nervous system: Cerebral hemorrhage
  • Gastrointestinal: Gallbladder disease
  • Hepatic: Hepatic adenoma, hepatic neoplasm (benign)
Adverse reactions considered drug related:
  • Cardiovascular: Edema, worsening of varicose veins
  • Central nervous system: Depression, exacerbation of tics, migraine
  • Dermatologic: Allergic skin rash, chloasma
  • Endocrine & metabolic: Amenorrhea, breast changes (breast hypertrophy, breast secretion, breast tenderness, mastalgia), decreased serum folate level, exacerbation of porphyria, menstrual disease (menstrual flow changes), weight changes
  • Gastrointestinal: Abdominal cramps, bloating, carbohydrate intolerance, nausea, vomiting
  • Genitourinary: Breakthrough bleeding, cervical ectropion, cervical erosion, change in cervical secretions, decreased lactation (with use immediately postpartum), infertility (temporary), spotting, vulvovaginal candidiasis
  • Hepatic: Cholestatic jaundice
  • Hypersensitivity: Anaphylaxis/anaphylactoid reaction (including angioedema, circulatory shock, respiratory collapse, urticaria)
  • Neuromuscular & skeletal: Exacerbation of systemic lupus erythematosus
  • Ophthalmic: Change in corneal curvature (steepening), contact lens intolerance
Adverse reactions in which association is not confirmed or denied:
  • Cardiovascular: Budd-Chiari syndrome
  • Central nervous system: Dizziness, headache, nervousness
  • Dermatologic: Acne vulgaris, erythema multiforme, erythema nodosum, loss of scalp hair
  • Endocrine & metabolic: Change in libido, hirsutism, porphyria, premenstrual syndrome
  • Gastrointestinal: Change in appetite, colitis, pancreatitis
  • Genitourinary: Cystitis-like syndrome, dysmenorrhea, vaginitis
  • Hematologic & oncologic: Hemolytic-uremic syndrome, hemorrhagic eruption
  • Ophthalmic: Cataract, optic neuritis (with or without partial or complete loss of vision)
  • Renal: Renal insufficiency